Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,128,242
-$264,698 QoQ
Shares Held
71,646
-1.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.64%
of 13F equity value
Holder Rank
#602
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Round Hill Asset Management holds $42,939,237 across 7 Drug Manufacturers - General names. BMY ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
37,380 | $13,536,045 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,350 | $9,168,475 | |
| 3 | NVO |
Novo Nordisk A S
|
122,031 | $5,850,166 | |
| 4 | PFE |
Pfizer Inc
|
242,134 | $5,830,586 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
71,646 | $4,128,242 | |
| 6 | ABBV |
AbbVie Inc.
|
15,475 | $3,894,129 | |
| 7 | NVS |
Novartis AG
|
3,392 | $531,594 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,128,242 | 71,646 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,392,940 | 72,431 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,947,491 | 73,183 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,186,360 | 70,651 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,116,239 | 45,717 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $957,603 | 15,701 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $591,843 | 10,464 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $541,407 | 10,464 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $434,569 | 10,464 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $567,462 | 10,464 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $543,065 | 10,584 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $614,295 | 10,584 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $676,846 | 10,584 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $733,577 | 10,584 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $761,518 | 10,584 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $752,416 | 10,584 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $814,968 | 10,584 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $772,949 | 10,584 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $659,912 | 10,584 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $626,255 | 10,584 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $707,222 | 10,584 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $668,167 | 10,584 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $656,525 | 10,584 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $638,109 | 10,584 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $622,339 | 10,584 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $589,952 | 10,584 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||